KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
- Calm Prevails Over Border Areas In S. Lebanon Following Ceasefire Deal
- Zionist Airstrikes Target 10 Syria-Lebanon Border Crossings, Killing Six Civilians
- Moroccan King Urges “Decisive Action” To Achieve Ceasefire In Palestinian Territories
- Global Media Congress Kicked Off In UAE
- Biden Says Israel-Hezbollah Ceasefire Deal “Designed To Be” Permanent
- G7 Foreign Ministers Urge Israel To Comply With Int’l Law
- Sri Lanka To Call For Nominations For Long-Delayed Local Government Elections
- 8th ASEAN Media Forum Kicked Off In Laos, Focusing On Regional Integration
- Russia Could Deploy Missiles In Asia If U.S. Missiles Appear There: Deputy FM
- Indonesia To Run Regional Elections Tomorrow